Coenzyme Q10 CoQ10 is a fat-soluble quinone compound mainly found in mitochondria, where it plays a key role in cellular ATP production. Conventional crystalline CoQ10 has been widely used in dietary supplements and pharmaceutical products for decades. However, its large molecular weight, strong hydrophobicity, and poor water solubility significantly limit oral absorption and bioavailability. To overcome these limitations, formulation technologies have advanced from micronization and oil-based soft capsules to nanotechnology-based carrier systems. Among these innovations, Liposome Coenzyme Q10 has become an important approach for improving CoQ10 absorption and stability. So, what are the main differences between Liposomal CoQ10 and Regular CoQ10?
What are the differences between Liposomal CoQ10 and Regular CoQ10?
Comparison of Physicochemical Properties and Forms of Existence
Crystal Characteristics of Regular Coenzyme Q10
Regular Coenzyme Q10 typically exists in crystalline form. This crystal structure exhibits strong intermolecular forces, making it insoluble and even difficult to wet in aqueous media. In the gastrointestinal environment, untreated regular Coenzyme Q10 crystals readily aggregate, resulting in a small effective contact area. It must rely on dietary fats and bile acids to emulsify it into mixed micelles before it can be taken up by intestinal epithelial cells. This process is affected by multiple factors, including individual bile secretion and dietary fat content, leading to significant batch-to-batch fluctuations in blood drug concentration.
The "Bionic" Structure of Liposome Coenzyme Q10
Liposome technology utilizes a phospholipid bilayer as a carrier. Phospholipid molecules have hydrophilic heads and hydrophobic tails, spontaneously forming closed vesicle structures in water. For liposomal Coenzyme Q10 CoQ10, the raw material is encapsulated within the hydrophobic core of the phospholipid bilayer.
This change in form leads to two key technical changes:
• Elimination of crystalline morphology:
Elimination of crystalline morphology: During liposome encapsulation, Liposome Coenzyme Q10 transforms from a crystalline state to an amorphous or molecularly dispersed state. The energy required to break the crystal lattice is eliminated, which is a prerequisite for improving saturated solubility.
• Improved apparent solubility:
Phospholipid vesicles endow coenzyme Q10 with the property of being "water-dispersible." Liposome Coenzyme Q10 CoQ10 form a colloidal dispersion system in the liquid, which macroscopically solves the technical problem of ordinary coenzyme Q10 being insoluble in water.
Absorption Mechanism and Bioavailability
There are fundamental differences in the absorption pathways of the two substances in vivo, with specific comparative data as follows.
|
Comparison Dimensions: |
Regular Coenzyme Q10 |
Liposome coenzyme Q10 |
|
Molecular/Particle State |
Crystalline powder, highly hydrophobic, with extremely low water solubility |
Liposome coenzyme Q10 is encapsulated in a phospholipid bilayer, existing in an amorphous or dissolved state with good water dispersibility. |
|
Gastrointestinal Dissolution Process |
Requires dissolution of the crystals, relying on emulsification with bile salts and dietary lipids to form mixed micelles |
It skips the crystal dissolution step, pre-dispersing the liposome structure and directly entering the absorption process. |
|
Main Absorption Mode |
Passive diffusion (dependent on concentration gradient) |
It utilizes multiple mechanisms in parallel: endocytosis + membrane fusion + passive diffusion. |
|
Dependence on Dietary Lipids |
Highly dependent (absorption rate significantly decreases under low-fat/fat-free diets) |
It has low dependence (the endocytosis/membrane fusion pathway is independent of micelle formation). |
|
Rate-Limiting Steps of Absorption |
Crystal dissolution + micelle formation |
Liposome uptake efficiency in intestinal epithelial cells. |
Limitations of Conventional Coenzyme Q10 Absorption
The absorption of conventional Coenzyme Q10 follows a "dissolution-diffusion" model. After oral administration, the drug must first dissolve from the solid crystals and then be transported via the lymphatic system. Research data shows that the absolute bioavailability of conventional Coenzyme Q10 is typically less than 10%. Furthermore, aging leads to a decline in Coenzyme Q10 CoQ 10 levels in the body, and older adults generally have weakened lipid metabolism, further limiting the effectiveness of traditional formulations in target populations (such as those at risk of cardiovascular disease).
Advantages of Liposome Coenzyme Q10 Transmembrane Transport
Liposome Coenzyme Q10 bypasses the traditional dissolution and absorption barriers through the following pathways:
• Physical stability and protection:
The phospholipid bilayer protects the gastrointestinal tract, preventing Coenzyme Q10 from being oxidized or degraded before reaching the absorption site.
• Endocytosis:
While traditional substances rely on diffusion, liposome particles, as exogenous vesicles, can be directly taken up by Peyer's knots of small intestinal epithelial cells or by intestinal epithelial cells through endocytosis. This is an energy-dependent active transport process, less affected by the intestinal lipid environment.
• Lymphatic targeting:
The Liposome Coenzyme Q10 CoQ10 enters the lymphatic system intact, entering the bloodstream via the thoracic duct, avoiding the first-pass effect of the liver.
According to data from a randomized crossover clinical trial published in Food & Function, compared to regular coenzyme Q10, the new generation of liposomal coenzyme Q10 CoQ10, showed a 4.3-fold increase in AUC<sub>0-t</sub> (area under the curve) and a 3.6-fold increase in C<sub>max</sub> (peak concentration).
How To Use Liposome Coenzyme Q10 in Formulation?
Q10 products not only improve absorption but also solve the physical compatibility issues of traditional formulations.
Compatibility with Functional Food and Beverage
Ordinary coenzyme Q10, due to its strong hydrophobicity, quickly floats on the surface and adheres to the bottle wall when added to transparent beverages. Liposomal ubiquinol CoQ10 not only causes inaccurate dosage but also results in a poor appearance.
Liquid liposomes are converted into solid powder through spray drying technology. This liposomal ubiquinol CoQ10 powder has good flowability and can be directly used in direct compression technology to produce tablets or in stick packs of solid beverages. Their cold water dispersibility meets the needs of modern fast-paced consumption habits.
Balancing High Dosage and Enhanced Efficacy
From a formulation cost perspective, although the raw material price of liposomal coenzyme Q10 is higher than that of ordinary coenzyme Q10, its bioavailability is 3-4 times higher. To achieve equivalent plasma concentrations, formulators can significantly reduce the dosage. For example, the efficacy that would require 200mg of ordinary coenzyme Q10 may only require 50-100mg of high-quality liposomal coenzyme Q10 CoQ10. This has a significant commercial advantage in formulation development where supply is tight or tablet volume needs to be reduced.
Cosmetics and Transdermal Applications
For the cosmetics industry, transdermal absorption of coenzyme Q10 is a major challenge. Ordinary powders cannot penetrate the stratum corneum. However, liposomal CoQ10 ubiquinol with a particle size controlled at 100-200nm has a structure similar to skin lipids, enabling it to penetrate the interstitial spaces and deliver the active ingredient to the deep epidermis.
Conclusion:
Liposome CoQ10 is not a simple physical mixture of ordinary raw materials. It is an advanced dosage form technology. Its nanoscale phospholipid vesicle structure helps solve the key problem of CoQ10 being poorly soluble and difficult to absorb. For B2B clients, choosing liposome-based CoQ10 can improve product differentiation. It also provides greater formulation flexibility and supports compliance and efficacy requirements.
Guanjie Biotech uses its global supply chain experience to optimize production processes. The company provides a range of liposome CoQ10 raw materials with high encapsulation efficiency, good powder flowability, and strong stability. These products support the development needs of B2B clients across different application fields.
References:
[1] Jäger, R., et al. (2025). Impact of liposomal delivery on coenzyme Q10 absorption. Frontiers in Nutrition.
[2] Next-generation liposomal coenzyme Q10: from formulation to clinical evidence. (2026). Food & Function.
[3] Comparative review of translational approaches in lipid-based and water-based encapsulation strategies for coenzyme Q10. (2025). Drug Delivery and Translational Research.
[4] Research on the Preparation of Coenzyme Q10 Nanoliposomes. Food Industry Science and Technology.
[5] Zhu, M. J., Fang, S. Q., Xu, J., Wu, J., Miao, J. Y., Ma, L., Liu, W., & Zou, L. Q. (2025). Preparation, characterization and study on bioaccessibility improvement of crystal-modified coenzyme Q10 nanostructured lipid carriers. Food and Fermentation Industries, 51(21), 270-276.
[6] Shoviantari, F. (2017). Efektivitas, Iritabilitas, dan Stabilitas Fisik Coenzim Q10 dalam Sistem Penghantaran Nanoemulsi dan Nanostructured Lipid Carriers sebagai Kosmetika Antiaging [Master's thesis, Universitas Airlangga].
[7] Shoviantari, F. (2017). Efficacy, irritation and physical stability of coenzyme Q10 as an anti-aging cosmetic in nanoemulsion and nanostructured lipid carrier delivery systems [Master's Thesis, University of El Langa].
